Annual securities reports (有価証券報告書) filed on EDINET — management narrative only (statistics tables, financial-statement notes, director remuneration and cross-shareholding disclosure are excluded). TSE corporate-governance reports and TDnet are separate documents and are not read here.
K Pharma,Inc. 4896
| Cost of capital | no mention | matched by rule |
|---|---|---|
| PBR | no mention | matched by rule |
| Metric | no metric named | matched by rule |
| Target | no numeric target | matched by rule |
| Payout | policy language, no number 「また、当面は、多額の先行投資を伴う研究開発活動の継続的かつ計画的な実施に備えた資金の確保を優先するため、配当等の株主還元は行わない方針としております」BusinessRisksTextBlock | matched by rule |
For desks: your watchlist through these questions, kept current each filing season. Custom, from $999+.
Reply with your names